RESUMEN
BACKGROUND: Recently, reports of endoscopic approaches for neuroblastoma, ganglioneuroblastoma, and ganglioneuroma (peripheral neuroblastic tumor; PNTs) have been increasing. This study aimed to clarify the indications for endoscopic surgery for PNTs. METHODS: Pediatric patients who underwent endoscopic surgery for PNTs at our institution were included in this study. Image-defined risk factors (IDRFs) were analyzed using preoperative computed tomography (CT). RESULTS: Twenty-four patients underwent endoscopic surgery for PNTs. The diagnoses included neuroblastoma (n = 11), ganglioneuroma (n = 10), and ganglioneuroblastoma (n = 3). Regarding the tumor site, there were 18 cases of adrenal tumors, five cases of mediastinal tumors, and one case of retroperitoneal tumors. Image-defined risk factors were positive in eight cases (contacted with a renal vessel, n = 6; compression of principal bronchi, n = 2). Complete resection was accomplished in 21 cases (14 of 16 IDRF-negative cases and seven of eight IDRF-positive cases). All patients survived without recurrence during the follow-up period. CONCLUSIONS: The CT findings of contact with renal vessels and compression of principal bronchi do not seem to be indicators of incomplete resection. An endoscopic approach to PNTs in pediatric patients is feasible with a good prognosis if patients are selected strictly.
Asunto(s)
Ganglioneuroblastoma , Ganglioneuroma , Neuroblastoma , Tomografía Computarizada por Rayos X , Humanos , Masculino , Femenino , Preescolar , Neuroblastoma/cirugía , Neuroblastoma/diagnóstico , Niño , Lactante , Ganglioneuroma/cirugía , Ganglioneuroma/diagnóstico , Ganglioneuroblastoma/cirugía , Ganglioneuroblastoma/diagnóstico , Estudios Retrospectivos , Endoscopía/métodos , Resultado del Tratamiento , Adolescente , Estudios de Seguimiento , Neoplasias de las Glándulas Suprarrenales/cirugía , Neoplasias de las Glándulas Suprarrenales/diagnóstico , Neoplasias del Mediastino/cirugía , Neoplasias del Mediastino/diagnósticoRESUMEN
Background. Ganglioneuroblastoma is a borderline tumor of sympathetic origin that is considered a childhood disease, with the majority of patients occurring in children less than five years old and few patients occurring in adults. There are no treatment guidelines for adult ganglioneuroblastoma. Here, we report a rare patient of adult gastric ganglioneuroblastoma that was completely resected by a laparoscopic approach. Case presentation. A 73-year-old man presented with dull pain in the upper abdomen along with abdominal distension for one month. Gastroscopy examination revealed chronic gastritis and submucosal tumors of the gastric antrum. Endoscopic ultrasonography showed a hypoechoic mass in the gastric antrum arising from the muscularis propria. An abdominal computed tomography scan revealed an irregular soft tissue mass in the gastric antrum with heterogeneous enhancement in the arterial phase. The mass was completely resected by laparoscopic surgery. Postoperative histopathology revealed that the mass contained differentiated neuroblasts, mature ganglion cells and ganglioneuroma components. The pathological diagnosis was ganglioneuroblastoma intermixed, and the patient was determined to be in stage I. The patient received no adjuvant chemotherapy or radiotherapy. At his two-year follow-up, the patient was doing well and showed no signs of recurrence. Conclusion. Despite the rarity of gastric ganglioneuroblastoma as a primary site of origin, it should be considered in the differential diagnosis of gastric masses in adults. Radical surgery is sufficient for the treatment of ganglioneuroblastoma intermixed, and long-term follow-up should be performed.
Asunto(s)
Ganglioneuroblastoma , Neoplasias Gástricas , Anciano , Humanos , Masculino , Endosonografía , Ganglioneuroblastoma/diagnóstico , Ganglioneuroblastoma/cirugía , Gastroscopía , Neoplasias Gástricas/diagnóstico , Neoplasias Gástricas/cirugíaRESUMEN
Peripheral neuroblastic tumors represent the fourth-largest group of malignant tumors in childhood. The majority of these tumors are neuroblastomas, which can be classified into undifferentiated, poorly differentiated, and differentiating subtypes. In addition, peripheral neuroblastic tumors include ganglioneuroblastoma, a composite tumor composed of Schwannian cell stroma and neuroblasts as well as benign ganglioneuroma. In this overview, histopathological diagnostic criteria and grading systems, as well as common molecular alterations that are of prognostic and therapeutic significance, are discussed.
Asunto(s)
Ganglioneuroblastoma , Ganglioneuroma , Neuroblastoma , Tumores Neuroectodérmicos Primitivos , Humanos , Neuroblastoma/diagnóstico , Ganglioneuroblastoma/diagnóstico , Pronóstico , Ganglioneuroma/diagnóstico , Células del Estroma/patologíaRESUMEN
BACKGROUND: Ganglioneuroblastoma intermixed (GNBI) is classified as "favorable" histology by International Neuroblastoma Pathology Classification system. However, the International Neuroblastoma Risk Group (INRG) stratifies patients using wider clinicopathological and cytogenetic/molecular parameters. While the diagnosis of GNBI is typically made on resected tumor, it may sometimes be rendered on initial biopsy. We studied GNBI noted at diagnosis to evaluate its correlation with INRG staging and other clinicopathological and molecular features. METHODS: In this retrospective study, clinical, radiological, pathological, cytogenetic, and molecular information from patients with GNBI at diagnosis seen between 1995 and 2021 was analyzed. INRG staging was performed. RESULTS: Of the 15,827 neuroblastoma specimens, GNBI was noted in 237 patients. Of these, 53 had the initial pathological diagnosis of GNBI; median follow-up 3.5 (range: 0.2-14) years. Disease was locoregional in 41 (77%, 16 stage L1 and 25 L2); none relapsed. Twelve (23%) had metastatic disease at presentation; six (50%) relapsed, and two died of disease. MYCN was amplified in two metastatic tumors. Six of 31 (19%) tumors tested had recurrent cytogenetic abnormalities and nonrecurrent somatic gene mutations in 10/23 (43%). The presence of any adverse molecular/cytogenetic findings was associated with metastatic disease (p < .05). For patients with localized GNBI undergoing both biopsy and resection, GNBI was diagnosed in both in 17/19 (90%). CONCLUSIONS: Localized GNBI at diagnosis has excellent long-term clinical outcome even without cytotoxic therapy. For localized GNBI, a biopsy sample is adequate to make the diagnosis. When associated with metastasis at diagnosis, prognosis is poorer, possibly due to associated adverse biological features.
Asunto(s)
Ganglioneuroblastoma , Neuroblastoma , Humanos , Lactante , Ganglioneuroblastoma/diagnóstico , Ganglioneuroblastoma/genética , Ganglioneuroblastoma/patología , Estudios Retrospectivos , Neuroblastoma/patología , Pronóstico , Genómica , Estadificación de NeoplasiasRESUMEN
BACKGROUND: Neuroblastomas are the most common extracranial solid malignancy in children with variable manifestations and complications depending on the presence of paraneoplastic syndromes. MATERIALS AND METHODS: We performed a single institution retrospective cohort study of all patients less than 18 years old diagnosed with neuroblastoma or ganglioneuroblastoma between January 2002 and July 2022. Patients were identified through the pathology and cancer registry and cross-referenced with pediatric records. Patient demographics, clinical presentation, treatment, and outcomes were collected. A univariate descriptive analysis of the collected data was conducted. RESULTS: In our study period, 130 children were diagnosed with neuroblastoma, and 15 were diagnosed with ganglioneuroblastoma. There were 12 children with a paraneoplastic syndrome identified, 8 with NBL and 4 with ganglioneuroblastoma (GNBL). The average age at diagnosis was 22 months. All but 1 underwent resection prior to treatment of paraneoplastic syndrome, and 4 children required neoadjuvant therapy. Neurological complications were the most common with 10 children (83%). The average time from symptom onset to diagnosis was 0.7 months. Eight children had complete resolution of their symptoms after treatment and resection, 2 children recently started treatment within a year, 1 had partial resolution, and 1 died during treatment. The presence of tumor-infiltrating lymphocytes occurred in 4 children with neurologic paraneoplastic syndromes. Six children had neuropil rich tumors. CONCLUSION: The histological profile of paraneoplastic syndromes of neuroblastoma and ganglioneuroblastoma and their treatment across a single institution can be highly variable. The presence of tumor-infiltrating lymphocytes and neuropil may have an impact on paraneoplastic pathology.
Asunto(s)
Ganglioneuroblastoma , Enfermedades del Sistema Nervioso , Neuroblastoma , Síndromes Paraneoplásicos , Humanos , Niño , Lactante , Adolescente , Ganglioneuroblastoma/complicaciones , Ganglioneuroblastoma/diagnóstico , Ganglioneuroblastoma/cirugía , Estudios Retrospectivos , Neuroblastoma/complicaciones , Neuroblastoma/terapia , Neuroblastoma/patología , Síndromes Paraneoplásicos/terapia , Síndromes Paraneoplásicos/complicacionesRESUMEN
Background: Peripheral neuroblastic tumors arise from the sympathoadrenal lineage of the neural crest. They have been classified according to the International Neuroblastoma Pathology Committee (INPC) into Four categories according to International Neuroblastoma Pathology Committee (INPC): a) Neuroblastoma (NB) b) Ganglioneuroblastoma (GNB), nodular c) Ganglioneuroblastoma, intermixed, and d) Ganglioneuroma (GN). Because of the rarity of extra-adrenal peripheral neuroblastic tumors, limited information is available regarding the chemotherapy of NB and GNB. A few case reports or case series with a small number of patients have been documented in the literature. Aim: To describe the clinicopathological characteristics of extra-adrenal peripheral neuroblastic tumors. Materials and. Methods: Clinical, histopathological, and immunohistochemistry (IHC) findings of 18 cases were retrieved. Immunohistochemistry at the time of diagnosis was performed using Ventana Benchmark XT. The mean value was calculated using the Microsoft Office Excel 2019 software. Results: The posterior mediastinum was the most commonly affected extra-adrenal site in our study. Neuroblastoma consisted of eight cases (six in children, two in adults), of which four cases were poorly differentiated and the other four cases were differentiating. Two cases had favorable histology. The bone marrow and cervical lymph node metastasis were documented. Of the four GNB cases, one patient developed bone metastasis. All patients of NB and GNB received combination chemotherapy. One out of six GN patients presented with a large retroperitoneal mass encasing the aorta and renal vessels, mimicking a sarcoma. Conclusion: Extra-adrenal peripheral neuroblastic tumors do not pose any diagnostic issue in adequate tissue sampling. In limited material, immunohistochemistry is needed. The chemotherapy regimen has not been standardized due to rarity. Further molecular testing and targeted therapy may be of help in the future.
Asunto(s)
Ganglioneuroblastoma , Ganglioneuroma , Neuroblastoma , Niño , Humanos , Ganglioneuroblastoma/diagnóstico , Ganglioneuroblastoma/patología , Neuroblastoma/diagnóstico , Inmunohistoquímica , Ganglioneuroma/diagnósticoRESUMEN
El ganglioneuroblastoma es un tumor derivado de los neuroblastos, generalmente originado a partir de estructuras simpáticas, típicamente localizado en la glándula suprarrenal. En este artículo presentamos un caso excepcional de una paciente de 6 años con un ganglioneuroblastoma cervical que desarrolló trastornos del sueño derivados de la compresión de la vía aérea desde su primer año de vida. (AU)
Ganglioneuroblastoma is a tumor derived from neuroblasts, generally related to sympathetic structures, which is usually located in the adrenal gland. In this article, we present a rare case of a patient with cervical ganglioneuroblastoma, who developed sleep disorders since the first year of life due to compression of the airway. (AU)
Asunto(s)
Humanos , Femenino , Niño , Ganglioneuroblastoma/diagnóstico , Ganglioneuroblastoma/cirugía , Neoplasias , Neuroblastoma , Trastornos del Sueño-VigiliaRESUMEN
PURPOSE: Ganglioneuroma (GN) and ganglioneuroblastoma-intermixed (GNB-I) represent benign variants of neuroblastic tumors in children; however, differentiating from more aggressive histological variants of GNB including the nodular subtype (GNB-N) prior to resection can be challenging, even with biopsy. Currently, no standard treatment guidelines exist. The purpose of this study was to identify pre-operative characteristics of benign neuroblastic tumors and evaluate outcomes for patients who underwent surgical resection or observation. METHODS: Retrospective chart review of children treated at a single institution between 2009 and 2019 for non-metastatic tumor with a tissue diagnosis of GN, GNB-N or GNB-I. Demographics, imaging, labs, operative details and outcomes were recorded and analyzed. RESULTS: Of 53 patients, 45% were male. The most common tumor location was abdomen (49%), followed by thorax (34%). Forty-five percent had at least one image defined risk factor. Biopsy was performed in 32% (17/53) and upfront surgery in 68% (36/53). Three patients (3/53, 5.6%) with biopsy demonstrating GN tumors were observed due to high surgical risk. Pathology of resected specimens demonstrated GN in 52% (26/50) and GNB-I or GNB-N in 48% (24/50). The majority of GNB tumors (75% (18/24) were GNB-I and 25% (6/24) were GNB-N. Therefore, 88% of the resected tumors were benign spectrum neuroblastic tumors (GN & GNB-I). Seven (7/50, 14%) patients experienced perioperative complication (temporary paralysis, Horner's syndrome, chylothorax, vocal cord paralysis). Recurrence was noted in 1 patient with GN (1/50, 2%) and 3 with GNB-N (3/50, 6%). There were no tumor-related deaths. Patients with GN were older than those with GNB (8.8 years (IQR 6-11.25) vs 5.6 years for GN (IQR 3-7); p = 0.01). GNB tumors were also more likely to have calcifications on imaging (63% vs. 38%, p = .01) and more commonly had MIBG avidity (88% vs 66%, p = .04). There were no significant differences in tumor size or symptoms at presentation. CONCLUSIONS: In children with neuroblastic tumors, older age, CT without tumor calcifications, lack of MIBG avidity, and/or normal urine catecholamines may indicate benign GN. Close observation could be considered for asymptomatic patients meeting these criteria with biopsy-proven GN, with resection reserved for progressive growth or symptom development. However, larger, multicenter studies are needed for further validation. LEVEL OF EVIDENCE: IV.
Asunto(s)
Ganglioneuroblastoma , Ganglioneuroma , Neuroblastoma , Niño , Femenino , Ganglioneuroblastoma/diagnóstico , Ganglioneuroblastoma/patología , Ganglioneuroblastoma/cirugía , Ganglioneuroma/diagnóstico , Ganglioneuroma/patología , Ganglioneuroma/cirugía , Humanos , Masculino , Neuroblastoma/diagnóstico , Neuroblastoma/patología , Neuroblastoma/cirugía , Estudios RetrospectivosRESUMEN
BACKGROUND: Nodular ganglioneuroblastoma is a rare peripheral neuroblastic tumor of variable prognosis. Accurate diagnosis, staging, and risk categorization can be particularly challenging in patients with nodular ganglioneuroblastoma due to the inherent heterogeneity of these lesions. CASE PRESENTATION: We illustrate the use of diffusion-weighted magnetic resonance imaging to identify tumor nodules and guide tumor biopsy in an almost 5-year-old boy with a large abdominal tumor. CONCLUSIONS: Diffusion-weighted magnetic resonance imaging was successful in detecting and guiding biopsy of a poorly differentiated neuroblastoma nodule within the context of a well-differentiated ganglioneuroma, allowing the diagnosis and characterization of a ganglioneuroblastoma nodular, thus influencing the child's prognosis and treatment.
Asunto(s)
Neoplasias Abdominales/diagnóstico , Imagen de Difusión por Resonancia Magnética/métodos , Ganglioneuroblastoma/diagnóstico , Ganglioneuroma/diagnóstico , Biopsia Guiada por Imagen/métodos , Neoplasias Abdominales/cirugía , Preescolar , Diagnóstico Diferencial , Ganglioneuroblastoma/cirugía , Ganglioneuroma/cirugía , Humanos , Masculino , PronósticoRESUMEN
CONTEXT: Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, autonomic dysregulation and neural crest tumor (ROHHHAD[NET]) is a rare and potentially fatal disease. No specific diagnostic biomarker is currently available, making prompt diagnosis challenging. Since its first definition in 2007, a complete clinical analysis leading to specific diagnosis and follow-up recommendations is still missing. OBJECTIVE: The purpose of this work is to describe the clinical timeline of symptoms of ROHHAD(NET) and propose recommendations for diagnosis and follow-up. DESIGN: We conducted a systematic review of all ROHHAD(NET) case studies and report a new ROHHAD patient with early diagnosis and multidisciplinary care. METHODS: All the articles that meet the definition of ROHHAD(NET) and provide chronological clinical data were reviewed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis individual patient data guidelines. The data were grouped into 7 categories: hypothalamic dysfunction, autonomic dysregulation, hypoventilation, NET, psychiatric symptoms, other clinical manifestations, and outcome. RESULTS: Forty-three individual patient data descriptions were analyzed. The timeline of the disease shows rapid-onset obesity followed shortly by hypothalamic dysfunction. Dysautonomia was reported at a median age of 4.95 years and hypoventilation at 5.33 years, or 2.2 years after the initial obesity. A NET was reported in 56% of the patients, and 70% of these tumors were diagnosed within 2 years after initial weight gain. CONCLUSION: Because early diagnosis improves the clinical management and the prognosis in ROHHAD(NET), this diagnosis should be considered for any child with rapid and early obesity. We propose guidance for systematic follow-up and advise multidisciplinary management with the aim of improving prognosis and life expectancy.
Asunto(s)
Neoplasias de las Glándulas Suprarrenales/diagnóstico , Enfermedades del Sistema Nervioso Autónomo/diagnóstico , Ganglioneuroblastoma/diagnóstico , Ganglioneuroma/diagnóstico , Enfermedades Hipotalámicas/diagnóstico , Hipoventilación/diagnóstico , Obesidad/diagnóstico , Neoplasias de las Glándulas Suprarrenales/complicaciones , Enfermedades del Sistema Nervioso Autónomo/complicaciones , Ganglioneuroblastoma/complicaciones , Ganglioneuroma/complicaciones , Humanos , Enfermedades Hipotalámicas/complicaciones , Hipoventilación/complicaciones , Obesidad/complicaciones , Pronóstico , SíndromeRESUMEN
OBJECTIVE: The aim of this analysis was to describe the cytopathology spectrum of peripheral neuroblastic tumours (NTs) including neuroblastoma (NB), ganglioneuroblastoma (GNB) and ganglioneuroma (GN). Feasibility of applying the International Neuroblastoma Pathology Classification (INPC) to further subtype NTs in cytology was evaluated. METHODS: All peripheral NTs reported on fine needle aspiration during 2011-2015 were retrieved and detailed cytomorphological evaluation was performed. Based on INPC criteria, NBs were further categorised as undifferentiated, poorly differentiated and differentiating subtypes. Mitotic-karyorrhectic index was evaluated. Immunocytochemistry on cell blocks was reviewed wherever available. MYCN amplification by fluorescence in situ hybridisation was performed in 11 cases on smears. RESULTS: A total of 90 cases including 83 NBs, six GNB and one GN were evaluated. The age range was 12 days-12 years, with 55 males and 45 females. Both the primary and metastatic locations were aspirated. Applying the INPC criteria, there were 61 poorly differentiated, 14 undifferentiated, eight differentiating NB and six GNB. Immunocytochemistry on cell blocks showed positivity for at least two neuronal markers in NB. Mitotic-karyorrhectic index was high in 63, low in 22 and intermediate in two cases, respectively. MYCN amplification by fluorescence in situ hybridisation was feasible on smears and was amplified in 6 out of 11 cases tested. CONCLUSION: Peripheral NT types including NB, GNB and GN have distinctive cytomorphology. NBs can be further subtyped as undifferentiated, poorly differentiated and differentiating subtypes as per INPC criteria.
Asunto(s)
Biopsia con Aguja Fina/métodos , Ganglioneuroblastoma/diagnóstico , Ganglioneuroma/diagnóstico , Neuroblastoma/diagnóstico , Niño , Preescolar , Citodiagnóstico/métodos , Diagnóstico Diferencial , Femenino , Ganglioneuroblastoma/clasificación , Ganglioneuroblastoma/patología , Ganglioneuroma/clasificación , Ganglioneuroma/patología , Humanos , Lactante , Recién Nacido , Masculino , Neuroblastoma/clasificación , Neuroblastoma/patología , PronósticoRESUMEN
INTRODUCTION: Neuroblastoma ranks third among pediatric malignancies. CASE REPORT: The case of a 3-year-old child is presented, who suddenly had frequent, unproductive, emetic cough; fever; and weight loss. Lung X-ray showed an opacity situated in the posterior superior mediastinum. Thoracic ultrasound revealed a slightly inhomogeneous, hypoechoic mass located in the posterior superior mediastinum. Computed tomography evidenced a tumor mass with homogeneous appearance in the costo-vertebral groove. Histological examination confirmed the diagnosis of ganglioneuroblastoma. CONCLUSION: Although history and clinical examination provided few elements, diagnosis was made based on imaging and histopathological examination.
Asunto(s)
Ganglios Simpáticos/patología , Ganglioneuroblastoma/diagnóstico , Neoplasias del Sistema Nervioso Periférico/diagnóstico , Preescolar , Ganglioneuroblastoma/patología , Ganglioneuroblastoma/cirugía , Humanos , Masculino , Neoplasias del Sistema Nervioso Periférico/patología , Neoplasias del Sistema Nervioso Periférico/cirugíaRESUMEN
BACKGROUND: Peripheral neuroblastic tumours arising from primitive cells of the cranial and spinal ganglia and from sympathetic ganglion cells of the autonomic nervous system include, from most to least differentiated, ganglioneuroma, ganglioneuroblastoma and neuroblastoma. Canine ganglioneuroblastoma has been described in the mediastinum, nasal and oral cavities, as well as in the brain. OBJECTIVE: To describe the clinical and histopathological findings, treatment and follow-up of a primary cutaneous ganglioneuroblastoma affecting the footpad of a dog. ANIMAL: An 8-year-old male German shepherd dog, referred for left forelimb lameness and licking of the footpad, showed thickening of the footpad of digit V with a central nodular lesion. METHODS AND RESULTS: Histopathological and immunohistochemical examination on a surgical skin biopsy specimen showed an infiltrative and highly cellular neoplasm in the deep dermis. The neoplasm was composed of large polyhedral cells with abundant cytoplasm containing Nissl substance that reacted strongly with neuron-specific enolase and neuronal nuclei antigen, spindle cells with indistinct cell borders suggestive of Schwann cells, with a mild S-100 and GFAP immunoreactivity, and rare nests of neuroblasts. The owner agreed to digit amputation. Histologically, a neoplastic multinodular proliferation with morphological findings like those detected in the biopsy was observed, not extended to the surgical margins and without involvement of skeletal bone. No recurrence or metastasis was observed over a period of one year. CONCLUSIONS AND CLINICAL IMPORTANCE: To the best of the authors' knowledge, this is the first report of a primary cutaneous ganglioneuroblastoma in a dog. Ganglioneuroblastoma should be included in the differential diagnoses of canine footpad neoplastic diseases.
Asunto(s)
Enfermedades de los Perros/diagnóstico , Pie/patología , Ganglioneuroblastoma/veterinaria , Animales , Biopsia , Diagnóstico Diferencial , Perros , Ganglioneuroblastoma/diagnóstico , Masculino , Piel/patologíaRESUMEN
The RNA-binding protein HuC/D displays a neuron-specific expression and is involved in neuronal differentiation and the maintenance of the nervous system. Here we investigated the diagnostic value of HuC/D in neuroblastomas. We evaluated 85 neuroblastic tumors: 81 neuroblastomas; 3 ganglioneuroblastomas, intermixed; 1 ganglioneuroma, maturing; and 101 other tumors consisting of 34 Ewing sarcomas, 14 nephroblastomas, 11 rhabdomyosarcomas, 15 pulmonary small cell carcinomas, 18 pancreatic neuroendocrine tumors, and 9 pheochromocytomas. Immunohistochemistry for HuC/D, PHOX2B, and tyrosine hydroxylase was performed. The immunoreactivity for HuC/D was semiquantified using the total score (TS; range, 0-8). HuC/D positivity was defined as a TS ≥6. The TS of the neuroblastic tumors (mean TS, 7.94) was significantly higher than those of the other small round cell tumors and neuroendocrine tumors (P < .001) except for the pheochromocytomas (mean TS, 6.89; P = .074). HuC/D was positive in all 85 neuroblastic tumors, 1 (2.9%) Ewing sarcoma, 1 (6.7%) pulmonary small cell carcinoma, and 8 (89%) pheochromocytomas. PHOX2B was positive in all of the neuroblastic tumors and pheochromocytomas. Tyrosine hydroxylase was positive in 80 (94%) neuroblastic tumors, 1 (9.1%) rhabdomyosarcoma, and all of the pheochromocytomas. Therefore, HuC/D serves as a highly sensitive diagnostic marker to distinguish neuroblastomas from other small round cell tumors. The combination of HuC/D and PHOX2B staining may be valuable for the diagnosis of neuroblastic tumors, especially in the assessment of small sections. HuC/D expression in tumors may be related to catecholamine production or a neural crest-derived cell origin.
Asunto(s)
Neoplasias de las Glándulas Suprarrenales/diagnóstico , Carcinoma de Células Pequeñas/diagnóstico , Proteína 3 Similar a ELAV/metabolismo , Ganglioneuroblastoma/diagnóstico , Neuroblastoma/diagnóstico , Tumores Neuroendocrinos/diagnóstico , Neoplasias Pancreáticas/diagnóstico , Feocromocitoma/diagnóstico , Adolescente , Neoplasias de las Glándulas Suprarrenales/metabolismo , Neoplasias de las Glándulas Suprarrenales/patología , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma de Células Pequeñas/metabolismo , Carcinoma de Células Pequeñas/patología , Niño , Preescolar , Diagnóstico Diferencial , Femenino , Ganglioneuroblastoma/metabolismo , Ganglioneuroblastoma/patología , Proteínas de Homeodominio/metabolismo , Humanos , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad , Neuroblastoma/metabolismo , Neuroblastoma/patología , Tumores Neuroendocrinos/metabolismo , Tumores Neuroendocrinos/patología , Neoplasias Pancreáticas/metabolismo , Neoplasias Pancreáticas/patología , Feocromocitoma/metabolismo , Feocromocitoma/patología , Sensibilidad y Especificidad , Factores de Transcripción/metabolismo , Adulto JovenRESUMEN
Introducción: el ganglioneuroblastoma es un tumor infrecuente del sistema nervioso simpático, intermedio entre el neuroblastoma maligno y el ganglioneuroma benigno. Es común en niños y raro en adultos. Objetivo: presentar el caso de un paciente adulto con ganglioneuroblastoma retroperitoneal bien diferenciado, de importancia por ser infrecuente.Presentación del caso: paciente masculino de 34 años. Presentó dolor en la región dorsolumbar izquierda, punzante y localizado, intensificado con los movimientos. Posteriormente aparecieron otros síntomas que motivaron el ingreso. En el examen físico se detectó en el hipocondrio y flanco izquierdo una masa tumoral, observada en los exámenes imagenológicos. Con posterioridad a la intervención quirúrgica, el resultado del estudio histopatológico confirmó que se trató de un ganglioneuroblastoma.Discusión: el diagnóstico de estos tumores se basa en el estudio imagenológico. No obstante, los estudios histopatológico e inmunohistoquímico permiten su diagnosis certera. El tratamiento es quirúrgico, debido a que los reportes médicos muestran que las respuestas a la radioterapia y quimioterapia son malas en tumores irresecables o metastásicos. Al paciente se le aplicaron seis ciclos de quimioterapia con vincristina, epirrubicina y ciclofosfamida.Conclusiones: la relevancia de este caso está dada por ser el ganglioneuroblastoma retroperitoneal bien diferenciado un tumor raro en adultos. En este caso no fue posible resecar el ganglioneuroblastoma en su totalidad y se empleó quimioterapia adyuvante, a la que el paciente respondió favorablemente(AU)
Introduction: is an infrequent tumor of the sympathetic nervous system, intermediate betweenmalignant neuroblastoma and benign ganglioneuroma. It is common in children and rare in adults. Objective: to present the case of an adult patient with well-differentiated retroperitonealganglioneuroblastoma, of importance because it is infrequent. Case presentation: male patient of 34 years. He presented pain in the left thoracolumbar region, sharp and localized, intensified with the movements. Later, other symptoms thatmotivated the admission appeared. In the physical examination, a tumor mass was detected in the hypochondrium and left flank, observed in the imaging tests. Subsequent to the surgical intervention, the result of the histopathological study confirmed that it was a ganglioneuroblastoma. Discussion: the diagnosis of these tumors is based on the imaging study. However,histopathological and immunohistochemical studies allow accurate diagnosis. The treatment issurgical, because medical reports show that responses to radiotherapy and chemotherapy are poor in unresectable or metastatic tumors. Six cycles of chemotherapy with vincristine, epirubicinand cyclophosphamide were applied to the patient. Conclusions: the relevance of this case is given by the well-differentiated retroperitonealganglioneuroblastoma is a rare tumor in adults. In this case it was not possible to resect the ganglioneuroblastoma in its entirety and adjuvant chemotherapy was used, to which the patient responded favorably(AU)
Asunto(s)
Humanos , Masculino , Adulto Joven , Neoplasias/cirugía , Neoplasias/diagnóstico , Cavidad Peritoneal/cirugía , Ganglioneuroblastoma/cirugía , Ganglioneuroblastoma/diagnóstico , Informes de CasosRESUMEN
RATIONALE: Ganglioneuroblastoma is usually located in the adrenal gland, retroperitoneal ganglia, or posterior mediastinum, but rarely occurs in the parapharyngeal space. PATIENT CONCERNS: A 4-year-old girl presented with complaint of progressive inspiratory dyspnea and dysphagia, accompanying left-side Horner's syndrome. DIAGNOSE: Computed tomography (CT) scan revealed a giant mass with irregular low density in left oropharyngeal and posterior pharyngeal wall. The left carotid artery sheath was pushed to the right. After enhancement, the central part of the mass was strengthened, and the surrounding bones structures appeard normal. Magnetic resonance imaging (MRI) showed a solid mass in the left parapharyngeal space displacing the left carotid sheath posteriorly and laterally. A ganglioneuroblastoma was diagnosed. INTERVATIONS: The girl was treated by surgery. OUTCOMES: The postoperative course was uneventful. There was no recurrence was observed during the 1-year follow-up. LESSONS: The primary cervical ganglioneuroblastoma is rare, we recommended the ganglioneuroblastoma should be considered in the differential diagnosis of a child presenting with a parapharyngeal space mass.
Asunto(s)
Ganglioneuroblastoma/diagnóstico , Ganglioneuroblastoma/cirugía , Neoplasias de la Médula Espinal/diagnóstico , Neoplasias de la Médula Espinal/cirugía , Médula Cervical , Preescolar , Diagnóstico Diferencial , Femenino , Ganglioneuroblastoma/patología , Humanos , Neoplasias de la Médula Espinal/patologíaRESUMEN
BACKGROUND: Mycobacterium tuberculosis (M. tuberculosis) disease is a generally well-known problem among immunocompromised adults and children. In pediatric oncology, only few cases of M. tuberculosis disease are reported so far. CASE PRESENTATION: We report a case of concomitant lymphnode tuberculosis in a 4-year-old German boy with relapsed ganglioneuroblastoma. 18 months after the initial diagnosis, relapse with new paravertebral lesions and new lesions in the left lower lobe of the lung and in the perihilar lymphnodes suspicious of metastases of the ganglioneuroblastoma were detected. While relapse in the tumor was confirmed, unexpectedly, pathologic examination revealed morphological diagnosis of lymphnode tuberculosis. The boy was of German background without previous history of tuberculosis exposure. Both, antituberculostatic and relapse treatment were immediately initiated. Three months on, MRI revealed regressive findings in the lung and lymphnodes and partial response in the tumor. The patient underwent second MiBG therapy and haploidentical stem cell transplantation. CONCLUSION: The diagnosis of lymphnode tuberculosis in a 4-year-old German boy with relapsed ganglioneuroblastoma was only made by chance, but most likely saved his life. Pediatric oncologist should be aware of tuberculosis as the incidence might increase over time and the timely diagnosis of a potentially preventable M. tuberculosis disease is irreplaceable. Further studies are needed to explore the incidence of M. tuberculosis infections and the value of IGRA, testing for latent tuberculosis infection prior to chemotherapy in children with underlying malignancies.
Asunto(s)
Ganglioneuroblastoma/diagnóstico , Tuberculosis Ganglionar/diagnóstico , Antituberculosos/farmacología , Preescolar , Ganglioneuroblastoma/complicaciones , Humanos , Huésped Inmunocomprometido , Interferón gamma/metabolismo , Pulmón/diagnóstico por imagen , Ganglios Linfáticos/diagnóstico por imagen , Imagen por Resonancia Magnética , Masculino , Mycobacterium tuberculosis/aislamiento & purificación , Recurrencia Local de Neoplasia , Tuberculosis Ganglionar/complicaciones , Tuberculosis Ganglionar/tratamiento farmacológico , Tuberculosis Ganglionar/microbiologíaRESUMEN
Chronic abdominal pain is a very common complaint in the population of children and adolescents. In most cases, the usual cause are functional gastrointestinal disorders. However, in a few percent of children, the reason for persistent chronic stomach pain are organic diseases occurring in the gastrointestinal tract, as well as parenteral diseases, including uro-genital tract abnormalities, inflammation of the lower respiratory tract and cancer processes. Among organic causes, in addition to those commonly encountered, such as: intolerances and food allergies, gastroesophageal reflux disease, chronic gastritis or duodenitis, or urinary tract infections, the diagnosis should also include very rare causes, for example, neoplastic diseases, among them tumors of the abdominal cavity. In the case described in the present article, a 6-year-old girl with chronic abdominal pain, symptoms of gastro-oesophageal reflux and constipation, and previously diagnosed food allergy and lactose intolerance, was referred for widening the diagnosics due to the occurrence of alarm symptoms. The nodule revealed in the chest X-ray, in CT scan, turned out to be a paravertebral tumor with the specific features of neuroblastoma. After a macroscopically complete tumor resection based on the result of histopathological examination, the diagnosis of ganglineuroblastoma was established. The presence of alarm symptoms in anamnesis and physical examination in children with abdominal pain suggests a higher probability of the organic origin of the disease and should always lead to extended diagnostics. Ganglioneuroblastoma is a very rare disease, in most cases is located primarily in the abdominal cavity, and the most common associated symptom is abdominal pain.
Asunto(s)
Dolor Abdominal/etiología , Ganglioneuroblastoma/diagnóstico , Ganglioneuroblastoma/terapia , Enfermedades Gastrointestinales/etiología , Neoplasias de la Médula Espinal/diagnóstico , Neoplasias de la Médula Espinal/terapia , Niño , Femenino , Humanos , Examen Físico/métodos , Resultado del TratamientoRESUMEN
BACKGROUND: Ganglioneuroblastoma is a tumor of peripheral neuroblastic tissue which occurs predominantly in the pediatric age group; it is a rare occurrence in the newborn period with only one case reported at birth to date. CASE PRESENTATION: We report the case of a newborn male baby of Brahmin ethnicity from Nepal who presented with respiratory distress and blueberry muffin skin lesions after birth. A computed tomography scan showed a mass lesion in the posterior mediastinum, which was diagnosed as ganglioneuroblastoma on fine-needle aspiration cytology. He also had metastases to multiple sites including heart, lungs, skin and brain. CONCLUSIONS: Ganglioneuroblastoma is a rare tumor in newborns. Any newborn presenting with respiratory distress associated with blueberry muffin skin lesions should be evaluated for neuroblastic tumor.